Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#GlobalHealthcareLogisticsMarket–Technavio has been monitoring the healthcare logistics market and it is poised to grow by USD 30.93 billion during…
LONDON–(BUSINESS WIRE)–#GlobalHealthcareLogisticsMarket–Technavio has been monitoring the healthcare logistics market and it is poised to grow by USD 30.93 billion during…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…
Abivax has doest the first patient with an iNKT agonist, ABX196, in a Phase 1/2 study to evaluate safety, tolerability and preliminary efficacy of the combination therapy. ABX196 is Abivax’s second compound in clinical development, following its lead candidate ABX464 in inflammatory diseases.
Clinician with deep experience in DMD drug development (ex-Sarepta Therapeutics Director) On the ground presence in the US to accelerate…
Asprihale® is intended for emergency treatment to reduce the risk of vascular mortality in patients with suspected acute myocardial infarction…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB :ASPCF) will announce financial results for the three and twelve month periods ending December…
— U.S. FDA Grants Investigational New Drug Authorization to Study Remdesivir for the Treatment of COVID-19 — FOSTER CITY, Calif.–(BUSINESS…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…